Research confirms that physical fitness peaks at 35, but there's encouraging news about what you can do to slow the ...

Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...

EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...

‘Our study shows that physical activity can slow the decline in performance, even if it cannot completely stop it,’ says the ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) ...

A decades-long Swedish study finds that physical decline starts around age 35, but exercise at any age still meaningfully preserves fitness. A Swedish research project spanning 47 years from ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the ...

The extreme weight loss seen in many late-stage cancer patients, known as cachexia, is far more than a cosmetic side effect.

THE striking degree of malnutrition that may accompany chronic congestive heart failure has been termed cardiac cachexia. Hippocrates was perhaps the first to record this association between dropsy ...

New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight The cancer cachexia ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients experience, according to a new study from University of Illinois Chicago ...